Generic Combivir is in a group of medicines called reverse transcriptase inhibitors. It is used for treating HIV infection in combination with other medicines.
Generic Norvir is an antiviral medication in a group of HIV medicines called protease inhibitors. It prevents human immunodeficiency virus (HIV) cells from multiplying in your body.
Generic Relenza is used to treat flu symptoms caused by influenza virus in patients who have had symptoms for less than 2 days. It may also be given to prevent influenza in people who may be exposed but do not yet have symptoms.
Ziagen is used, in combination with other medicines, in the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the virus that causes acquired immunodeficiency syndrome (AIDS). Abacavir will not cure or prevent HIV infection or AIDS; however, it helps keep HIV from reproducing and appears to slow down the destruction of the immune system.
Idenix Says FDA Lifts Partial Hold On Hepatitis Drug IDX184; But Stock Down - NASDAQ
CitybizlistIdenix Says FDA Lifts Partial Hold On Hepatitis Drug IDX184; But Stock DownNASDAQIDX184 is a pan-genotypic oral nucleotide polymerase inhibitor, and has showed a high resistance in vitro and potent antiviral activity in trials.
Consider antiviral meds to combat flu - Jackson Clarion Ledger
Consider antiviral meds to combat fluJackson Clarion LedgerNowadays, those who are diagnosed with the flu within two days of having symptoms, have the option of taking prescribed antiviral medications to lessen the severity of the virus.
Gilead tops table for antivirals - Pharma Times
Gilead tops table for antiviralsPharma TimesWith combined sales from the top HIV treatment on the market, Atripla, and several other drugs, Gilead Sciences leads the antiviral market, closely followed by Bristol-Myers Squibb, Roche and Merck & Co.
Antiviral RNAi: From Molecular Biology Towards Applications ESF-EMBO Symposium - Nature.com
Antiviral RNAi: From Molecular Biology Towards Applications ESF-EMBO SymposiumNature.
BMS spends $2.5 billion on antiviral firm - Chemistry World
.gif)
.gif)
